rs119482084

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2

The NM_006415.4(SPTLC1):ā€‹c.1160G>Cā€‹(p.Gly387Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000557 in 1,613,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00039 ( 0 hom., cov: 33)
Exomes š‘“: 0.00057 ( 0 hom. )

Consequence

SPTLC1
NM_006415.4 missense

Scores

4
13
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:2B:7O:1

Conservation

PhyloP100: 6.89
Variant links:
Genes affected
SPTLC1 (HGNC:11277): (serine palmitoyltransferase long chain base subunit 1) This gene encodes a member of the class-II pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is the long chain base subunit 1 of serine palmitoyltransferase. Serine palmitoyltransferase converts L-serine and palmitoyl-CoA to 3-oxosphinganine with pyridoxal 5'-phosphate and is the key enzyme in sphingolipid biosynthesis. Mutations in this gene were identified in patients with hereditary sensory neuropathy type 1. Alternatively spliced variants encoding different isoforms have been identified. Pseudogenes of this gene have been defined on chromosomes 1, 6, 10, and 13. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.833
BP6
Variant 9-92038342-C-G is Benign according to our data. Variant chr9-92038342-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 4802.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-92038342-C-G is described in Lovd as [Benign]. Variant chr9-92038342-C-G is described in Lovd as [Pathogenic]. Variant chr9-92038342-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000388 (59/152234) while in subpopulation AMR AF= 0.000784 (12/15302). AF 95% confidence interval is 0.000452. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 59 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTLC1NM_006415.4 linkuse as main transcriptc.1160G>C p.Gly387Ala missense_variant 13/15 ENST00000262554.7 NP_006406.1 O15269-1A0A024R277Q6NUL7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTLC1ENST00000262554.7 linkuse as main transcriptc.1160G>C p.Gly387Ala missense_variant 13/151 NM_006415.4 ENSP00000262554.2 O15269-1

Frequencies

GnomAD3 genomes
AF:
0.000388
AC:
59
AN:
152118
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000429
AC:
108
AN:
251488
Hom.:
0
AF XY:
0.000331
AC XY:
45
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000633
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000574
AC:
839
AN:
1461390
Hom.:
0
Cov.:
30
AF XY:
0.000575
AC XY:
418
AN XY:
727054
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000671
Gnomad4 ASJ exome
AF:
0.000191
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.000672
Gnomad4 OTH exome
AF:
0.000596
GnomAD4 genome
AF:
0.000388
AC:
59
AN:
152234
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.0000964
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000623
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000573
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000681
Hom.:
0
Bravo
AF:
0.000397
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000379
AC:
46
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:2Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuropathy, hereditary sensory and autonomic, type 1A Benign:2Other:1
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not provided, no classification providedliterature onlyGeneReviews-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 03, 2020- -
Charcot-Marie-Tooth disease Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Hereditary sensory and autonomic neuropathy type 1 Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMApr 01, 2009- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 20, 2024- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2023SPTLC1: BS3:Supporting, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxDec 06, 2019This variant is associated with the following publications: (PMID: 19132419, 21618344, 15037712, 19651702) -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 18, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.092
D
BayesDel_noAF
Pathogenic
0.27
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.77
D
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Pathogenic
0.81
D
MutationAssessor
Uncertain
2.8
M
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.1
D
REVEL
Pathogenic
0.81
Sift
Uncertain
0.013
D
Sift4G
Uncertain
0.032
D
Polyphen
0.41
B
Vest4
0.92
MVP
0.89
MPC
1.1
ClinPred
0.25
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.43
gMVP
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs119482084; hg19: chr9-94800624; COSMIC: COSV99364672; API